Pantoprazol Aurovitas (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Aurovitas, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Pantoprazol Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Aurovitas is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for: - Gastro‑oesophageal reflux disease (GERD): improves symptoms and promotes healing of the oesophageal lining. - Erosive esophagitis: accelerates healing of erosions caused by acid exposure. - Zoll‑Einstein syndrome: controls gastric acid hyper‑secretion associated with gastrin‑producing tumours. - Prevention of NSA‑induced gastric ulcers: reduces risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs. - Healing of duodenal ulcers: helps the helevant healing of the ulcer. - Long‑term management of acid‑related disorders that require continuous acid suppression to prevent symptom relapse and comp  

Pantoprazol  

Common   def: -   t  

Pantoprazol  t